Malin Corporation plc

03/10/2021 | Press release | Archived content

EmitBio Treatment Broadly Effective Against Coronavirus Variants

EmitBio Treatment Broadly Effective Against Coronavirus Variants

An important weapon in the global fight against an enemy that keeps evolving

Durham, N.C. (March 10, 2021) - EmitBio Inc., today announced new evidence that demonstrates its proprietary light technology can inactivate variants of the coronavirus that causes COVID-19, including the highly infectious United Kingdom and South Africa variants. These findings indicate important effectiveness against potentially more transmissible mutations of COVID-19.

Read the full press release
Company website
Malin Corporation plc published this content on March 10, 2021, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 22, 2025 at 09:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]